| Application no. and date | 03723907.6 (espacenet) (Federated) (European Patent Register), 20030404 | | Patent/reg. no. and date | DK/EP 1490066, 20080611 | | Publication date | 20041229 | | Priority no. and date | US 370150 P, 20020404, US 408292 P, 20020905, US 422589 P, 20021030 | | EP pub. no. and date |
EP 1490066 20041229 | | Effective date | | | Applicant/owner | Gilead Sciences, Inc., 333 Lakeside Drive
Foster City, California 94404, US | | Applicant ref. no. | P80800994DK00E | | Inventor | ANTZELEVITCH, Charles, 101 Sylvan Way
New Hartford, NY 13413, US,
BLACKBURN, Brent, 633 Almond Avenue
Los Altos, CA 94022, US,
BELARDINELLI, Luiz, 205 Manzanita Avenue
Palo Alto, CA 94306, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/495 (2006.01) , A61P 9/06 (2006.01) | | Title | Anvendelse af ranolazin til fremstilling af et medikament til behandling af arytmier | | Int. application no. | US2003010434 | | Int. publication no. | WO2003086401 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
